India pharma exports have crossed the $28 billion mark in FY26, highlighting the sector’s resilience and steady growth despite global economic uncertainties.
AstraZeneca liver cancer therapy is making headlines after the company reported positive Phase III results, showing its combination approach significantly slows disease progression in patients.
Alkem Strengthens Ujjain Expansion as Alkem Laboratories on Thursday announced it will nearly double its investment to Rs 1,036 crore for a greenfield formulations manufacturing facility in Ujjain, Madhya Pradesh.
Alembic Pharmaceuticals Limited has entered into a strategic partnership with Enthral.ai to roll out an advanced AI-powered skilling platform, marking a major step in modernizing its training ecosystem.
Marksans Pharma gets USFDA nod for benzonatate capsules, marking a key step in its push into the US generics market.
VLCC has taken a major step by introducing Global Laser Certification access in India through a new partnership with the National Council on Laser Certification (NCLC), USA. With this move, VLCC becomes the exclusive proctor for NCLC exams...
Fortis Hiranandani Hospital, Navi Mumbai, successfully hosted a train-the-trainer live surgical workshop on 28th March 2026, focusing on advanced gynecological endoscopy training amongst young practitioners.
Apollo Hospitals today announced a structured patient transfer initiative aimed at improving access to advanced critical care through coordinated air medical transportation across India and international regions.
Lupin Limited has received a USFDA tentative approval for daytime sleepiness drug, strengthening its position in the US generics market.
Year-end is where most pharma companies slip. Not because of big mistakes—but small misses in tax, filings, and documentation. In 2026, with the industry growing at 9-11%, tighter compliance matters more than ever.
.jpg)
, CDSCO.jpg)